Superoxide dismutase and xanthine oxidase activities in New Zealand rabbits treated with different types of glycosaminoglycans (GAGs) after osteoarthritis surgery

Chondroitin sulphate is one of the glycosaminoglycans (GAGs) generally acquired from animal tissues. CS has an anti-inflammatory, anti-apoptotic and antioxidant properties. The GAGs have been recently reported to possess the ability to influence oxidative stress known to lead to free radical mediated biological damage. Herein, we report the effect of some GAGs on superoxide dismutase (SOD) and xanthine oxidase (XO) activities in experimental animal models submitted to osteoarthritis surgery. In this respect, SOD and XO activities were investigated in New Zealand rabbits treated with different types of glycosaminoglycans (GAGs); commercial chondroitin sulphate (CCS) and bacterial chondroitin sulphate (BCS) (produced by using E. coli). The results of this study revealed that both CS sources significantly (P

PDF

___

1. Schiraldi C, Cimini D, De Rosa M. Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol. 2010;87:1209–20.

2. Willis LM, Whitfield C. Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways. Carbohydr Res. 2013;378:35–44.

3. Datta P, Linhardt RJ, Sharfstein ST. Industrial production of glycosaminoglycans. In: Encyclopedia of Microbiology. Elsevier; 2019. p. 681–90.

4. Miraglia N, Bianchi D, Trentin A, et al. Safety assessment of non-animal chondroitin sulfate sodium: Subchronic study in rats, genotoxicity tests and human bioavailability. Food Chem Toxicol. 2016;93:89–101.

5. Zhu W, Ji Y, Wang Y, et al. Structural characterization and in vitro antioxidant activities of chondroitin sulfate purified from Andrias davidianus cartilage. Carbohydr Polym. 2018;196:398–404.

6. Zhang Q, Yao R, Chen X, et al. Enhancing fructosylated chondroitin production in Escherichia coli K4 by balancing the UDP-precursors. Metab Eng. 2018;47:314–22.

7. He W, Fu L, Li G, et al. Production of chondroitin in metabolically engineered E. coli. Metab Eng. 2015;27:92–100.

8. Lin N, Mo X, Yang Y, et al. Purification and sequence characterization of chondroitin sulfate and dermatan sulfate from fishes. Glycoconj J. 2017;34:241–53.

9. Li Q, Cai C, Chang Y, et al. A novel structural fucosylated chondroitin sulfate from Holothuria Mexicana and its effects on growth factors binding and anticoagulation. Carbohydr Polym. 2018;181:1160–8.

10. Stephenson EL, Yong VW. Pro-inflammatory roles of chondroitin sulfate proteoglycans in disorders of the central nervous system. Matrix Biol. 2018;71–72:432–42.

11. Bobula T, Buffa R, Hermannová M, et al. The synthesis of a new unsaturated derivative of chondroitin sulfate with increased antioxidant properties. Carbohydr Polym. 2018;190:175–83.

12. Bougatef H, Krichen F, Capitani F, et al. Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect. Carbohydr Polym. 2018;196:272–8.

13. McIlwain H, Silverfield JC, Cheatum DE, et al. Intra-articular orgotein in osteoarthritis of the knee: A placebo-controlled efficacy, safety, and dosage comparison. Am J Med. 1989;87:295–300.

14. Campo GM, D’Ascola A, Avenoso A, Campo S, Ferlazzo AM, Micali C, et al. Glycosaminoglycans reduce oxidative damage induced by copper (Cu +2), iron (Fe+2) and hydrogen peroxide ($H_2 O_2$ ) in human fibroblast cultures. Glycoconj J. 2003;20:133–41.

15. Hart LI, McGartoll MA, Chapman HR, et al. The composition of milk xanthine oxidase. Biochem J. 1970;116:851–64.

16. Gilbert DL, Colton CA, Parks DA, et al. Xanthine Oxidase in Biology and Medicine. In: Reactive Oxygen Species in Biological Systems. Springer US; 2002. p. 397–420.

17. Baskın S, Salem H. Oxidants, Antioxidants And Free Radicals. 1st ed. Boca Racon: CRC Press; 1997.

18. Erenler AS, Geckil H, Karabulut AB, Akpolat N, Sevimli R, Ulke E, et al. Cloning and Expression vgb-kfo Genes in E. coli and Microbial Chondroitin Sulfate Production . Sci Adv Mater. 2019;11:1745–54.

19. Goering PL, Morgan DL, Ali SF. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol. 2002;22:167–72.

20. Prajda N, Weber G. Malignant transformation-linked imbalance: Decreased xanthine oxidase activity in hepatomas. FEBS Lett. 1975;59:245–9.

21. Esterbauer H, Ramos P. Chemistry and pathophysiology of oxidation of LDL. Rev Physiol Biochem Pharmacol. 1996;127:31–64.

22. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd ed. Free Radicals in Biology and Medicine. Oxford University Press; 2015.

23. Shull S, Heintz NH, Periasamy M, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem. 1991;266:24398–403.

24. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Vol. 64, Cell. 1991. p. 867–9.

25. Presti D, Scott JE. Hyaluronan mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH•) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct. 1994;12:281–8.

26. Albertini R, De Luca G, Passi A, et al. Chondroitin-4-sulfate protects highdensity lipoprotein against copper- dependent oxidation. Arch Biochem Biophys. 1999;365:143–9.

27. Arai H, Kashiwagi S, Nagasaka Y, et al. Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. Arch Biochem Biophys. 1999;367(1):1–8.

28. Sela S, Shurtz-Swirski R, Shapiro G, et al. Oxidative stress during hemodialysis: Effect of heparin. Kidney Int Suppl. 2001;59:S159–63.

29. Graf J, Neusel E, Schneider E, Niethard FU. Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: A controlled clinical trial versus mucopolysaccharide polysulfuric acid ester. Clin Exp Rheumatol. 1993;11:367–72.

30. Breborowicz A, Wieczorowska K, Martis L, et al. Glycosaminoglycan Chondroitin Sulphate Prevents Loss of Ultrafiltration during Peritoneal Dialysis in Rats. Nephron. 1994;67:346–50.

31. Shankland WE. The Effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: A preliminary report of 50 patients. CRANIO®. 1998;16:230–5.

32. Albertini R, Passi A, Abuja PM, et al. The effect of glycosaminoglycans and proteoglycans on lipid peroxidation. Int J Mol Med. 2000;6:129–36.

33. Volpi N, Tarugi P. Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate. J Biochem. 1999;125:297–304.